LYNN FOSTER

Lynn Foster is the Founder and CEO of BPT Pharmaceuticals, an early stage company focused on Multiple Sclerosis. He previously served as Emerging Technologies Director at Greenberg Traurig, L.L.P, one of the largest law firms in the United States. In that position he provided consulting services to clients on Technology Transfer, Patent Licensing and raising capital from Federal Research Grants, Venture Capital, and Strategic Investors.

Foster has the unique background of more than 15 years of experience with Technology Transfer and the federal grant process as a government manager at both the Federal and State and as an entrepreneur. He previously managed the State of California CalTIP seed grant program that matched federal research and development grants with commercialization funding. He also has 21 years of active and reserve service with the US Army including service in the first Gulf War and Bosnia.

Foster’s primary technical focus is Nanotechnology. He is the Editor and Co-Author of the best selling textbook, "Nanotechnology: Science, Innovation & Opportunity" (Prentice Hall, 2005). He has been quoted on technology and finance topics in numerous national and industry publications including The New York Times, Financial Times, Forbes and National Public Radio. He currently serves on the Executive Committee of the Caltech Enterprise Forum; the Advisory Board of Finaventures, a Venture Capital fund focused on early and mid-stage technology ventures; the Advisory Board of the Clean Technology and Sustainable Industries Organization; and the Nanotechnology and Emerging Technologies Committees of the US Chamber of Commerce. He has a B.S. from San Diego State University, and a M.B.A. from California State University, Long Beach.